LaNCE-Neuropharm: Laboratorio de Neurociencia Clínica y Experimental para el estudio farmacológico de la neuroprotección-neurodegeneración-neurorregeneración
Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina (7)
2021
-
Antipsychotics as environmental pollutants: An underrated threat?
Science of the Total Environment, Vol. 769
2019
-
Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation
Neurobiology of Disease, Vol. 121, pp. 252-262
2017
-
Morphological Changes in a Severe Model of Parkinson’s Disease and Its Suitability to Test the Therapeutic Effects of Microencapsulated Neurotrophic Factors
Molecular Neurobiology, Vol. 54, Núm. 10, pp. 7722-7735
2016
-
Intranasal administration of chitosan-coated nanostructured lipid carriers loaded with GDNF improves behavioral and histological recovery in a partial lesion model of Parkinson's disease
Journal of Biomedical Nanotechnology, Vol. 12, Núm. 12, pp. 2220-2230
2015
-
Topographical Distribution of Morphological Changes in a Partial Model of Parkinson’s Disease—Effects of Nanoencapsulated Neurotrophic Factors Administration
Molecular Neurobiology, Vol. 52, Núm. 2, pp. 846-858
2014
-
Increased antiparkinson efficacy of the combined administration of VEGF- and GDNF-loaded nanospheres in a partial lesion model of Parkinson's disease
International Journal of Nanomedicine, Vol. 9, Núm. 1, pp. 2677-2687
2013
-
In vivo administration of VEGF- and GDNF-releasing biodegradable polymeric microspheres in a severe lesion model of Parkinson's disease
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 85, Núm. 3 PART B, pp. 1183-1190